CHICAGO, IL
4 risk indicators measuring financial stability and operational resilience
Sign in with your work email to view Tuckman-Chang indicators
Sign In — Free (10 views/day)STAAR OVARIAN CANCER, founded in 2020, is a small nonprofit in the Medical Research sector that reported $400K in total revenue in fiscal year 2023. Revenue surged 29% from the prior year, signaling strong growth momentum. The organization ran a surplus of $123K, a strong 31% operating margin.
STAAR EXISTS TO ADVOCATE FOR AND RAISE FUNDS FOR RESEARCH SPECIFICALLY ON THE LOW-GRADE SEROUS CARCINOMA SUB-TYPE OF OVARIAN CANCER IN THE UNTED STATES. THROUGHOUT THE YEAR, WE DROVE AWARENESS OF THE SYMPTOMS OF OVARIAN CANCER AND THE UNDER-FUNDING OF RESEARCH FOR THE LGSC SUB-TYPE. WE MAKE CONNECTIONS WITH RESEARCHERS AND ULTIMATELY HAVE MADE THREE GRANTS, SOOME WITH FUNDS RAISED IN 2021.
CONTINUING SUPPORTING AND EXPANDING AN AWARENESS CAMPAIGN OF LGSOC.
AWARDED RESEARCH GRANTS FOR LGSOC
CREATED AND CONDUCTED A SURVERY OF LGSOC PATIENTS PERPECTIVES ON TREATMENTS AND DOCTOR INTERACTIONS WHICH ARE PRESENTED AT LGSOC RESEARCH CONFERENCE. PLAN, SUPPORT, AND HOLD AN EXTERNALLY-LED PATIENT...
CREATED AND CONDUCTED A SURVERY OF LGSOC PATIENTS PERPECTIVES ON TREATMENTS AND DOCTOR INTERACTIONS WHICH ARE PRESENTED AT LGSOC RESEARCH CONFERENCE. PLAN, SUPPORT, AND HOLD AN EXTERNALLY-LED PATIENT FOCUSED DRUG DEVELOPMENT MEETING AS DIRECTED BY THE US FDA FOR PATIENTS TO PRESENT THEIR PERSPECTIVES ON LIVING WITH THEIR RARE DISEASE AND THEIR DAILY LIFE WITH THE CURRENT TREATMENTS. PROVIDE A PLATFORM FOR PATIENTS TO SHARE THEIR THOUGHTS ON DRUG DEVELOPMENT AND SIDE EFFECTS.
Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency
Sign in to view Trantor Score and financial metrics
Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)
Sign In — Free (10 views/day)| 2023 | 2022 | Change | |
|---|---|---|---|
| Revenue | $399,588 | $310,800 | +0.3% |
| Expenses | $277,067 | $513,766 | -0.5% |
| Net Income | $122,521 | $-202,966 | -1.6% |
Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics
Financial Distress Indicator
Liquidity & Cash Position
Sign in to view all financial metrics
Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics
Sign In| Name | Title | Hours/Week | Role | Reportable Comp | Other Comp | Total |
|---|---|---|---|---|---|---|
| ELLIE HABIB | DIRECTOR | 2.00 |
Director
|
$0 | $0 | $0 |
| MADALYN KENNEY | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| BAILEY WOLFE | DIRECTOR | 1.00 |
Director
|
$0 | $0 | $0 |
| NICOLE ANDREWS | CHAIR | 10.00 |
Officer
|
$0 | $0 | $0 |
| CHRISTINA CAMPBELL | TREASURER | 2.00 |
Officer
|
$0 | $0 | $0 |
| MORGAN GAYNOR | SECRETARY | 2.00 |
Officer
|
$0 | $0 | $0 |
| KARI NEUMEYER | V-CHAIR MARK | 2.00 |
Officer
|
$0 | $0 | $0 |
| EMMA SCHLAMM | DIRECTOR | 2.00 |
Officer
|
$0 | $0 | $0 |
| ALYSSA TOOMES | V-CHAIR FUND | 2.00 |
Officer
|
$0 | $0 | $0 |
| Year | Revenue | Expenses | Assets | Net Income |
|---|---|---|---|---|
| 2024 | No data | No data | No data | No data |
| 2023 | $399,588 | $277,067 | $448,000 | $122,521 |
| 2022 | $310,800 | $513,766 | $164,305 | $-202,966 |
Compare STAAR OVARIAN CANCER with other nonprofits in Illinois and across the country.